Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $240.64 in the prior trading day, Steris Plc (NYSE: STE) closed at $241.56, up 0.38%. In other words, the price has increased by $0.38 from its previous closing price. On the day, 0.69 million shares were traded. STE stock price reached its highest trading level at $243.2 during the session, while it also had its lowest trading level at $240.84.
Ratios:
Our goal is to gain a better understanding of STE by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 85.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.25. For the most recent quarter (mrq), Quick Ratio is recorded 1.53 and its Current Ratio is at 2.22. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.29.
On May 29, 2025, Jefferies started tracking the stock assigning a Hold rating and target price of $263.
Piper Sandler Upgraded its Neutral to Overweight on October 24, 2024, whereas the target price for the stock was revised from $230 to $260.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 06 ’25 when Carestio Daniel A bought 159 shares for $241.82 per share.
Tamaro Renato sold 3,204 shares of STE for $798,565 on Aug 20 ’25. The V.P. & Corporate Treasurer now owns 7,221 shares after completing the transaction at $249.24 per share. On Aug 20 ’25, another insider, Tamaro Renato, who serves as the Officer of the company, bought 3,204 shares for $249.24 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STE now has a Market Capitalization of 23791390720 and an Enterprise Value of 25593391104. As of this moment, Steris’s Price-to-Earnings (P/E) ratio for their current fiscal year is 36.62, and their Forward P/E ratio for the next fiscal year is 21.88. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.02. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.27 while its Price-to-Book (P/B) ratio in mrq is 3.42. Its current Enterprise Value per Revenue stands at 4.594 whereas that against EBITDA is 17.008.
Stock Price History:
The Beta on a monthly basis for STE is 1.02, which has changed by 0.0634383 over the last 52 weeks, in comparison to a change of 0.15927899 over the same period for the S&P500. Over the past 52 weeks, STE has reached a high of $253.00, while it has fallen to a 52-week low of $200.98. The 50-Day Moving Average of the stock is -0.71%, while the 200-Day Moving Average is calculated to be 4.98%.
Shares Statistics:
The stock has traded on average 595.55K shares per day over the past 3-months and 638640 shares per day over the last 10 days, according to various share statistics. A total of 98.50M shares are outstanding, with a floating share count of 98.17M. Insiders hold about 0.33% of the company’s shares, while institutions hold 94.87% stake in the company. Shares short for STE as of 1757894400 were 1125341 with a Short Ratio of 1.89, compared to 1755216000 on 907139. Therefore, it implies a Short% of Shares Outstanding of 1125341 and a Short% of Float of 1.2999999.
Dividends & Splits
In the trailing 12 months, STE’s forward annual dividend rate was 2.28, compared to 2.34 this year. Against a Trailing Annual Dividend Yield of 0.009474734. The stock’s 5-year Average Dividend Yield is 0.88. The current Payout Ratio is 35.14% for STE, which recently paid a dividend on 2025-09-04 with an ex-dividend date of 2025-09-04. Stock splits for the company last occurred on 1998-08-25 when the company split stock in a 2:1 ratio.
Earnings Estimates
The stock of Steris Plc (STE) is currently in the spotlight, with 8.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $2.53, with high estimates of $2.56 and low estimates of $2.51.
Analysts are recommending an EPS of between $10.17 and $10.04 for the fiscal current year, implying an average EPS of $10.09. EPS for the following year is $11.04, with 9.0 analysts recommending between $11.21 and $10.64.
Revenue Estimates
8 analysts predict $1.43B in revenue for. The current quarter. It ranges from a high estimate of $1.44B to a low estimate of $1.41B. As of. The current estimate, Steris Plc’s year-ago sales were $1.33BFor the next quarter, 8 analysts are estimating revenue of $1.48B. There is a high estimate of $1.5B for the next quarter, whereas the lowest estimate is $1.45B.
A total of 9 analysts have provided revenue estimates for STE’s current fiscal year. The highest revenue estimate was $5.94B, while the lowest revenue estimate was $5.8B, resulting in an average revenue estimate of $5.9B. In the same quarter a year ago, actual revenue was $5.46BBased on 8 analysts’ estimates, the company’s revenue will be $6.28B in the next fiscal year. The high estimate is $6.32B and the low estimate is $6.15B.
